Literature DB >> 22122006

Sleep-promoting action of the endogenous melatonin in schizophrenia compared to healthy controls.

Pedro Afonso1, Maria Luísa Figueira, Teresa Paiva.   

Abstract

OBJECTIVE: The aim of this study was to compare the endogenous melatonin sleep-promoting effect in schizophrenic patients to a sample of healthy controls.
METHODS: Thirty-four schizophrenia outpatients (SP) and 34 healthy subjects (HS) participated in this study. Wrist-actigraphy recordings and a sleep diary were used for sleep-wake cycle assessment. The quality and patterns of sleep were measured with the Pittsburgh Sleep Quality Index (PSQI) and the Positive and Negative Syndrome Scale (PANSS) was used for psychopathology assessment. To quantify and assess nocturnal melatonin profiles, saliva samples were collected for one night under dim light conditions (<50 lux) hourly from 20:00 h to 23:00 h.
RESULTS: Scores on PSQI were significantly higher in SP as compared to HS, indicating a worse quality of sleep. Patients sleep more at night, but have poorer sleep efficiency, than HS. Sleep latency and nighttime awakenings were significant higher in SP. Melatonin levels were negatively correlated with sleep latency, total sleep time and positively correlated with sleep efficiency in HS but not in SP.
CONCLUSION: The results of the present study indicate that endogenous melatonin sleep-promoting action seems to be compromised in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22122006     DOI: 10.3109/13651501.2011.605954

Source DB:  PubMed          Journal:  Int J Psychiatry Clin Pract        ISSN: 1365-1501            Impact factor:   1.812


  14 in total

1.  Actigraphy studies and clinical and biobehavioural correlates in schizophrenia: a systematic review.

Authors:  Zi Ying Wee; Samantha Wei Lee Yong; Qian Hui Chew; Cuntai Guan; Tih Shih Lee; Kang Sim
Journal:  J Neural Transm (Vienna)       Date:  2019-03-19       Impact factor: 3.575

2.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

3.  Evidence for an association of serum melatonin concentrations with recognition and circadian preferences in patients with schizophrenia.

Authors:  Cigdem Sahbaz; Omer Faruk Özer; Ayse Kurtulmus; Ismet Kırpınar; Fikrettin Sahin; Sinan Guloksuz
Journal:  Metab Brain Dis       Date:  2019-02-13       Impact factor: 3.584

Review 4.  Melatonin: an overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects.

Authors:  George Anderson; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-04-25       Impact factor: 3.584

Review 5.  Clinical application of actigraphy in psychotic disorders: a systematic review.

Authors:  Masoud Tahmasian; Habibolah Khazaie; Sanobar Golshani; Kristin T Avis
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

Review 6.  Circadian rhythms and psychiatric illness.

Authors:  Lauren D Asarnow; Adriane M Soehner; Allison G Harvey
Journal:  Curr Opin Psychiatry       Date:  2013-11       Impact factor: 4.741

Review 7.  The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review.

Authors:  Sarah Reeve; Bryony Sheaves; Daniel Freeman
Journal:  Clin Psychol Rev       Date:  2015-09-09

8.  Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial.

Authors:  Lone Baandrup; Ole Bernt Fasmer; Birte Yding Glenthøj; Poul Jørgen Jennum
Journal:  BMC Psychiatry       Date:  2016-10-13       Impact factor: 3.630

Review 9.  Melatonin's neuroprotective role in mitochondria and its potential as a biomarker in aging, cognition and psychiatric disorders.

Authors:  Lindsay M Melhuish Beaupre; Gregory M Brown; Vanessa F Gonçalves; James L Kennedy
Journal:  Transl Psychiatry       Date:  2021-06-02       Impact factor: 6.222

Review 10.  Role of melatonin in schizophrenia.

Authors:  Armando L Morera-Fumero; Pedro Abreu-Gonzalez
Journal:  Int J Mol Sci       Date:  2013-04-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.